Form 4: Eastman Chemical Co: SVP, CLO & Corporate Secretary Acquires Restricted Stock Units
SEC Form 4 Filing
Bosede Ikeolu Gbadegesin, SVP, CLO & Corporate Secretary of Eastman Chemical Co, acquired 16,994 restricted stock units on October 1, 2024, which will vest on October 1, 2027, subject to continued employment.
Summary
- On October 1, 2024, Bosede Ikeolu Gbadegesin, the SVP, CLO & Corporate Secretary of Eastman Chemical Co [EMN], acquired 16,994 restricted stock units.
- These restricted stock units represent a contingent right to receive one share of Eastman Chemical Co common stock each.
- The units will vest and payout in unrestricted shares on October 1, 2027, contingent upon Ms. Gbadegesin's continued employment with the company.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a standard disclosure of stock unit acquisition by an executive, with no immediate positive or negative implications.
Future Outlook
The restricted stock units will vest and payout in unrestricted shares of Company stock on October 1, 2027, subject to Ms. Gbadegesin's continued employment.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to the market regarding the holdings and transactions of company executives. It is a standard practice for publicly traded companies to comply with SEC regulations regarding insider trading.
Stakeholder Impact
- The acquisition of restricted stock units by a company executive can align management's interests with those of shareholders, as the executive's compensation is tied to the company's stock performance.
Key Dates
| Date | Description |
|---|---|
| 10/01/2024 | Date of transaction: Bosede Ikeolu Gbadegesin acquired 16,994 restricted stock units. |
| 10/01/2027 | Vesting date for the restricted stock units, contingent upon continued employment. |
| 10/03/2024 | Date of filing of the Form 4. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.